HZNP•benzinga•
Horizon Therapeutics Q1 Adj. EPS $1.34 Beats $1.20 Estimate, Sales $885.20M Beat $874.41M Estimate; Reaffirms FY22 Guidance
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga